Back to Search
CANDICE JOHNSTONE, MD, MPH
MD, MPH
Radiation Oncology Physician
NPI: 1518982461IndividualAccepts Medicare
Specialties, Licenses & Credentials
Therapeutic Radiology Physician
Radiology — Therapeutic Radiology
Code: 2085R0203X
12688(NH)
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
55106(WI)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 2000
Research & Publications (20)
Living with peripheral vascular disease: a review of the literature.
PMID 12715535·Prof Nurse·2003
5-case
Analysis of the regulation of the A33 antigen gene reveals intestine-specific mechanisms of gene expression.
PMID 12114523·J Biol Chem·2002
7-preclinical
Characterization of mouse A33 antigen, a definitive marker for basolateral surfaces of intestinal epithelial cells.
PMID 10960348·Am J Physiol Gastrointest Liver Physiol·2000
7-preclinical
Making medicinal chemistry more effective--application of Lean Sigma to improve processes, speed and quality.
PMID 19508922·Drug Discov Today·2009
6-review
Low frequency of MLL3 mutations in colorectal carcinoma.
PMID 19215798·Cancer Genet Cytogenet·2009
4-observational
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.
PMID 19074899·Cancer Res·2008
8-other
Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes.
PMID 18753229·J Gen Virol·2008
7-preclinical
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
PMID 18458333·Proc Natl Acad Sci U S A·2008
8-other
Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylation.
PMID 17998334·Mol Cell Biol·2008
7-preclinical
The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.
PMID 17974918·Genes Dev·2007
7-preclinical
Traffic of proteins and peptides across membranes for immunosurveillance by CD8(+) T lymphocytes: a topological challenge.
PMID 17822406·Traffic·2007
6-review
IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms.
PMID 17457048·Cancer Biol Ther·2007
7-preclinical
TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice.
PMID 17408644·Gastroenterology·2007
7-preclinical
Large-scale sequencing of the colorectal cancer genome unearths novel pathways to tumorigenesis and provides potential druggable targets for cancer therapy.
PMID 17383441·Gastroenterology·2007
8-other
A quantitative assessment of hERG liability as a function of lipophilicity.
PMID 17239590·Bioorg Med Chem Lett·2007
8-other
Design of a potent, soluble glucokinase activator with excellent in vivo efficacy.
PMID 16503142·Bioorg Med Chem Lett·2006
8-other
Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats.
PMID 16921397·Br J Pharmacol·2006
7-preclinical
N-cadherin and keratinocyte growth factor receptor mediate the functional interplay between Ki-RASG12V and p53V143A in promoting pancreatic cell migration, invasion, and tissue architecture disruption.
PMID 16705170·Mol Cell Biol·2006
7-preclinical
Valuing river characteristics using combined site choice and participation travel cost models.
PMID 16380206·J Environ Manage·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 9200 W WISCONSIN AVE
MILWAUKEE, WI 53226 - Phone
- (414) 805-4400
Quick Facts
- NPI
- 1518982461
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile